CEO: Christopher Richard Anzalone

Sector: Health Technology
Industry:Biotechnology

Exchange: NASDAQ

Country: US

Description: Arrowhead Pharmaceuticals, Inc. operates as a biopharmaceutical company. It develops medicines that treat intractable diseases by silencing the genes that cause them. The company was founded by R. Bruce Stewart in 1989 and is headquartered in Pasadena, CA.


Key numbers

Market Capitalization:4508543900
Shares Outstanding: 101773000
Float: 92876208
Next Earning Date:2020-08-05
TTm EPS: 0.1141
TTm Dividend Rate:
200 days moving average:42.77
50 days moving average: 40.27
One day percent Change: -5.24



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-09-30, 2016-09-30, 2017-09-30, 2018-09-30,
2015-09-30, 2016-09-30, 2017-09-30, 2018-09-30,